Sustained secretion of anti-tumor necrosis factor α monoclonal antibody fromex vivogenetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis-Reference-Cited by-同舟云学术

Sustained secretion of anti-tumor necrosis factor α monoclonal antibody fromex vivogenetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis

Published:2017-08 Issue:8 Volume:19 Page:e2965
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J Gene Med

Author:

Zafir-Lavie Inbal¹,Miari Reem¹,Sherbo Shay¹,Krispel Simi¹,Tal Osnat¹,Liran Atar¹,Shatil Tamar¹,Badinter Felix¹,Goltsman Haim¹,Shapir Nir¹,Benhar Itai²,Neil Garry A.³,Panet Amos⁴

Affiliation:

1. Medgenics Medical Israel, Ltd; Misgav Israel

2. Department of Molecular Microbiology and Biotechnology, The George S. Wise Faculty of Life Sciences; Tel-Aviv University; Israel

3. Aevi Genomic Medicine, Inc.; Wayne Pennsylvania USA

4. Department of Biochemistry (IMRIC); The Hebrew University-Hadassah Medical School; Jerusalem Israel

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Reference52 articles.

1. Biological therapies for rheumatoid arthritis: Progress to date;Malviya;BioDrugs,2013

2. Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned?;Feldmann;Annu Rev Immunol,2001

3. Development of anti-TNF therapy for rheumatoid arthritis;Feldmann;Nat Rev Immunol,2002

4. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-fc fusion protein;Moreland;N Engl J Med,1997

5. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis;Elliott;Lancet,1994

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies: A Prospective and Retrospective View;Current Medicinal Chemistry;2021-02-01

2. Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells;Frontiers in Pharmacology;2020-07-03

3. Mechanism and Prevention of Titanium Particle-Induced Inflammation and Osteolysis;Frontiers in Immunology;2018-12-18

4. Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases;Journal of Controlled Release;2018-12